Radiation countermeasure agents: an update (2011 – 2014)

INTRODUCTION: Despite significant scientific advances over the past 60 years towards the development of a safe, nontoxic and effective radiation countermeasure for the acute radiation syndrome (ARS), no drug has been approved by the US FDA. A radiation countermeasure to protect the population at lar...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Vijay K, Newman, Victoria L, Romaine, Patricia LP, Wise, Stephen Y, Seed, Thomas M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438421/
https://www.ncbi.nlm.nih.gov/pubmed/25315070
http://dx.doi.org/10.1517/13543776.2014.964684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438421/
https://www.ncbi.nlm.nih.gov/pubmed/25315070
http://dx.doi.org/10.1517/13543776.2014.964684

Ejemplares similares